Format

Send to

Choose Destination
Leukemia. 2019 May 14. doi: 10.1038/s41375-019-0483-z. [Epub ahead of print]

getITD for FLT3-ITD-based MRD monitoring in AML.

Author information

1
Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
2
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.
3
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany. lars.bullinger@charite.de.
PMID:
31089248
DOI:
10.1038/s41375-019-0483-z

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center